Physician profile
Rufus Thrower
NPI 1588745046
$1,004.54
in general payments reported to CMS, 2019-2025
13 companies · $127 in 2025
The $127 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $216 · 2020: $263 · 2021: $215 · 2022: $80.40 · 2023: $68.91 · 2024: $33.57 · 2025: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $230.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $229.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $415.83 | 2019-2022 | |
| Abbvie INC. | $155.77 | 2019-2020 | |
| Abbott Laboratories | $127.34 | 2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Myovant Sciences INC. | $43.25 | 2021 | |
| Mylan Pharmaceuticals INC. | $42.14 | 2019-2022 | |
| Shield Therapeutics INC | $36.68 | 2023 | Accrufer |
| Mayne Pharma Commercial LLC | $36.57 | 2021-2023 | |
| Scynexis, INC. | $35.05 | 2022 | |
| Exeltis, USA INC. | $29.22 | 2023-2024 | Slynd |
| Evofem Biosciences, INC. | $25.76 | 2021 | |
| Lupin INC. | $23.40 | 2019-2020 | |
| Agile Therapeutics, INC. | $18.79 | 2024 | Twirla |
| Therapeuticsmd, INC. | $14.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rufus Thrower listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.